| Literature DB >> 31614794 |
So Young Woo1, So Young Ryu2, Fei Tian3, Sang Yoo Lee4, Su Been Park5, Hyang Sook Chun6.
Abstract
Doenjang, a Korean fermented soybean paste, is vulnerable to contamination by mycotoxins because it is directly exposed to environmental microbiota during fermentation. A method that simultaneously determines 20 mycotoxins in doenjang, including aflatoxins (AFs), ochratoxin A (OTA), zearalenone (ZEN), and fumonisins (FBs) with an immunoaffinity column cleanup was optimized and validated in doenjang using LC-MS/MS. The method showed good performance in the analysis of 20 mycotoxins in doenjang with good linearity (R2 > 0.999), intra- and inter-day precision (<16%), recovery (72-112%), matrix effect (87-104%), and measurement uncertainty (<42%). The validated method was applied to investigate mycotoxin contamination levels in commercial and homemade doenjang. The mycotoxins that frequently contaminated doenjang were AFs, OTA, ZEN, and FBs and the average contamination level and number of co-occurring mycotoxins in homemade doenjang were higher than those in commercially produced doenjang.Entities:
Keywords: doenjang; mycotoxins; simultaneous determination
Year: 2019 PMID: 31614794 PMCID: PMC6832528 DOI: 10.3390/toxins11100594
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Optimized LC-MS/MS parameters.
| Mycotoxin | Molar Mass (g/mol) | Precursor Ion | Molecular Ion | Product Ion | Retention Time (min) | |
|---|---|---|---|---|---|---|
| Quantifier | Qualifier | |||||
| AFB1 | 312.277 | 313.2 | [M + H]+ | 285.0 | 284.0 | 10.8 |
| AFB2 | 314.293 | 315.2 | [M + H]+ | 287.0 | 297.0 | 10.4 |
| AFG1 | 328.276 | 329.2 | [M + H]+ | 311.0 | 301.0 | 10.2 |
| AFG2 | 330.292 | 331.2 | [M + H]+ | 313.0 | 303.0 | 9.8 |
| OTA | 403.815 | 404.8 | [M + H]+ | 358.0 | 387.0 | 13.3 |
| ZEN | 318.369 | 319.3 | [M + H]+ | 301.0 | 283.0 | 13.2 |
| ZAN | 320.385 | 321.0 | [M + H]+ | 303.1 | 277.1 | 13.1 |
| α-ZEL | 320.385 | 321.0 | [M + H]+ | 285.1 | 259.1 | 12.9 |
| α-ZAL | 322.401 | 305.0 | [M + H − H2O]+ | 287.1 | 277.1 | 12.8 |
| β-ZEL | 320.385 | 303.0 | [M + H − H2O]+ | 285.1 | 267.1 | 12.4 |
| β-ZAL | 322.401 | 305.0 | [M + H − H2O]+ | 287.1 | 277.0 | 12.1 |
| T-2 | 466.527 | 489.5 | [M + Na]+ | 387.09 | 327.09 | 12.7 |
| HT-2 | 424.49 | 447.4 | [M + Na]+ | 345.0 | 285.0 | 12.2 |
| NIV | 312.318 | 357.2 | [M + HCOO-]- | 281.0 | 311.0 | 3.4 |
| DON | 296.319 | 341.3 | [M + HCOO-]- | 265.0 | 295.0 | 6.1 |
| 3ADON | 338.356 | 339.3 | [M + H]+ | 231.0 | 279.0 | 9.4 |
| D3G | 458.46 | 503.4 | [M + HCOO-]- | 457.1 | 427.1 | 6.6 |
| FB1 | 721.838 | 722.8 | [M + H]+ | 704.2 | 705.2 | 11.8 |
| FB2 | 705.839 | 706.8 | [M + H]+ | 688.3 | 530.3 | 12.8 |
| FB3 | 705.839 | 706.8 | [M + H]+ | 688.3 | 530.3 | 12.4 |
Figure 1LC-MS/MS Chromatograms of the mycotoxin analytes. Concentrations were as follows: 20 μg/kg for AFB1, AFB2, AFG1, AFG2, and OTA, and 1000 μg/kg for ZEN, ZAN, α-ZEL, α-ZAL, β-ZEL, β-ZAL, T-2, HT-2, NIV, DON, 3ADON, D3G, FB1, FB2, and FB3.
Figure 2Effects of the various cleanup methods on recoveries (A) and matrix effects (B).
Calibration curve, linearity, LOD, LOQ, and %SSE of the optimized method.
| Mycotoxin | Calibration Curve |
| LOD (μg/kg) | LOQ (μg/kg) | SSE (%) | ||
|---|---|---|---|---|---|---|---|
| Calibration Range (μg/kg) | Slope | Intercept | |||||
| AFB1 | 0.5−20 | 10,644.3 | −142.4 | 0.9999 | 0.08 | 0.26 | 89.7 |
| AFB2 | 0.5−20 | 8025.6 | −834.4 | 0.9998 | 0.14 | 0.43 | 94.6 |
| AFG1 | 0.5−20 | 8873.9 | 394.8 | 0.9999 | 0.10 | 0.30 | 100.8 |
| AFG2 | 0.5−20 | 6878.5 | −722.1 | 0.9999 | 0.15 | 0.45 | 98.7 |
| OTA | 0.5−20 | 20,887.2 | 8984.6 | 0.9998 | 0.06 | 0.17 | 87.0 |
| ZEN | 25−1000 | 4638.2 | −5420.4 | 0.9999 | 4.68 | 14.18 | 96.7 |
| ZAN | 25−1000 | 11,972.7 | −8964.7 | 1.0000 | 1.66 | 5.03 | 95.5 |
| α-ZEL | 25−1000 | 700.0 | −716.6 | 0.9999 | 1.47 | 4.44 | 94.2 |
| α-ZAL | 25−1000 | 2098.0 | 2773.7 | 0.9998 | 2.29 | 6.94 | 95.9 |
| β-ZEL | 25−1000 | 3649.0 | −12,582.2 | 1.0000 | 1.72 | 5.23 | 99.5 |
| β-ZAL | 25−1000 | 2042.0 | 8338.2 | 0.9997 | 2.13 | 6.45 | 101.9 |
| T-2 | 25−1000 | 23,047.8 | 411,783.3 | 0.9995 | 2.55 | 7.73 | 103.8 |
| HT-2 | 25−1000 | 18,293.4 | 257,935.3 | 0.9994 | 1.86 | 5.65 | 93.1 |
| NIV | 25−1000 | 1423.3 | −6891.8 | 0.9999 | 3.21 | 9.74 | 98.2 |
| DON | 25−1000 | 941.3 | −3171.0 | 1.0000 | 4.37 | 13.24 | 98.0 |
| 3ADON | 25−1000 | 821.9 | −5844.9 | 0.9999 | 0.9 | 2.73 | 100.4 |
| D3G | 25−1000 | 6246.2 | −12,849.3 | 0.9999 | 2.72 | 8.24 | 100.3 |
| FB1 | 25−1000 | 22,786.0 | −127,037.2 | 0.9998 | 2.57 | 7.78 | 98.1 |
| FB2 | 25−1000 | 24,992.8 | −211,390.0 | 1.0000 | 2.16 | 6.56 | 87.1 |
| FB3 | 25−1000 | 19,609.8 | −21,763.0 | 1.0000 | 2.22 | 6.72 | 86.5 |
Validation parameters: intra-/inter-day recovery and precision.
| Mycotoxin | %Recovery (%RSD) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Day ( | Inter-Day ( | |||||||||||||||
| 2 × LOQ * | 5 × LOQ | 10 × LOQ | 20 × LOQ | 2 × LOQ | 5 × LOQ | 10 × LOQ | 20 × LOQ | |||||||||
| AFB1 | 98.4 | (5.9) | 97.8 | (2.7) | 97.5 | (4.3) | 101.5 | (3.1) | 96.5 | (9.1) | 93.2 | (4.8) | 94.7 | (4.9) | 97.8 | (5.6) |
| AFB2 | 100.5 | (4.7) | 97.0 | (3.9) | 99.1 | (2.2) | 101.1 | (2.3) | 100.6 | (3.0) | 95.8 | (2.8) | 97.6 | (3.7) | 99.1 | (3.8) |
| AFG1 | 100.0 | (4.0) | 95.6 | (3.9) | 95.4 | (2.8) | 95.7 | (2.8) | 94.7 | (5.3) | 94.7 | (4.3) | 93.0 | (5.1) | 93.0 | (5.2) |
| AFG2 | 96.6 | (2.2) | 94.0 | (2.0) | 95.1 | (2.2) | 96.3 | (4.4) | 95.7 | (6.4) | 92.3 | (5.5) | 93.4 | (5.3) | 89.6 | (9.2) |
| OTA | 80.9 | (7.2) | 76.1 | (5.3) | 83.0 | (6.5) | 79.9 | (6.1) | 86.0 | (5.0) | 71.7 | (2.7) | 76.9 | (6.4) | 74.6 | (3.3) |
| ZEN | 89.4 | (3.6) | 85.7 | (5.0) | 83.1 | (7.3) | 84.1 | (5.1) | 90.8 | (5.4) | 83.3 | (5.1) | 83.8 | (8.7) | 85.2 | (6.5) |
| ZAN | 99.3 | (2.2) | 85.0 | (3.1) | 79.3 | (6.8) | 77.6 | (4.8) | 100.2 | (2.2) | 85.1 | (3.7) | 80.3 | (6.8) | 80.0 | (4.8) |
| α-ZEL | 104.5 | (3.3) | 93.4 | (5.0) | 88.6 | (6.2) | 85.1 | (4.6) | 103.6 | (4.0) | 92.0 | (4.5) | 87.9 | (9.1) | 86.7 | (5.8) |
| α-ZAL | 89.4 | (8.2) | 85.8 | (11.3) | 88.0 | (6.1) | 90.8 | (4.2) | 88.0 | (7.5) | 85.7 | (8.1) | 87.0 | (8.7) | 90.8 | (6.3) |
| β-ZEL | 105.6 | (3.2) | 89.4 | (3.9) | 83.5 | (7.4) | 82.0 | (4.0) | 109.6 | (3.1) | 91.0 | (3.3) | 85.0 | (7.3) | 84.1 | (3.6) |
| β-ZAL | 92.7 | (5.0) | 90.1 | (4.8) | 87.9 | (6.6) | 90.2 | (4.5) | 93.6 | (5.3) | 90.5 | (5.8) | 89.7 | (6.5) | 91.6 | (4.4) |
| T-2 | 75.7 | (16.2) | 92.0 | (10.4) | 96.0 | (12.6) | 94.7 | (12.6) | 75.0 | (4.5) | 91.9 | (6.0) | 96.4 | (8.2) | 97.6 | (6.6) |
| HT-2 | 79.2 | (5.3) | 74.3 | (13.7) | 76.6 | (12.5) | 83.0 | (11.5) | 86.8 | (5.8) | 72.6 | (13.2) | 78.9 | (12.7) | 82.1 | (15.2) |
| NIV | 95.2 | (15.2) | 89.5 | (7.4) | 89.5 | (12.6) | 84.3 | (8.9) | 112.3 | (5.9) | 97.1 | (7.6) | 86.7 | (13.4) | 85.5 | (8.1) |
| DON | 100.3 | (6.6) | 94.9 | (6.3) | 95.5 | (8.2) | 89.7 | (6.6) | 109.0 | (6.4) | 100.1 | (6.5) | 90.6 | (9.7) | 89.6 | (5.1) |
| 3ADON | 103.2 | (4.0) | 91.5 | (6.3) | 90.5 | (7.4) | 87.0 | (10.0) | 107.2 | (1.8) | 95.1 | (4.9) | 96.1 | (3.8) | 93.6 | (5.1) |
| D3G | 95.2 | (11.7) | 93.2 | (5.2) | 93.2 | (13.0) | 85.8 | (8.8) | 106.4 | (6.4) | 95.8 | (5.1) | 88.1 | (13.0) | 85.3 | (8.0) |
| FB1 | 94.3 | (11.0) | 99.5 | (8.0) | 95.1 | (5.1) | 83.8 | (6.7) | 93.2 | (8.2) | 103.5 | (7.4) | 92.3 | (13.2) | 90.3 | (7.9) |
| FB2 | 100.3 | (4.7) | 87.6 | (11.5) | 89.1 | (6.9) | 81.1 | (9.6) | 103.5 | (13.5) | 88.9 | (11.8) | 86.5 | (12.8) | 84.8 | (10.0) |
| FB3 | 96.6 | (4.1) | 87.0 | (11.2) | 91.2 | (6.8) | 82.2 | (5.8) | 97.6 | (11.7) | 88.6 | (9.4) | 88.8 | (12.9) | 84.2 | (10.3) |
* AFs and OTA: 1 μg/kg (2 × LOQ), 2 μg/kg (5 × LOQ), 3 μg/kg (10 × LOQ), 6 μg/kg (20 × LOQ); other mycotoxins: 15 μg/kg (2 × LOQ), 37 μg/kg (5 × LOQ), 74 μg/kg (10 × LOQ), 148 μg/kg (20 × LOQ).
Expanded uncertainty of each mycotoxin.
| Mycotoxin | Spiking Level (μg/kg) | Expanded Uncertainty | Uncertainty/Result (%) | Mycotoxin | Spiking Level (μg/kg) | Expanded Uncertainty | Uncertainty/Result (%) |
|---|---|---|---|---|---|---|---|
| AFB1 | 1 | 0.23 | 22.7 | β-ZAL | 15 | 1.18 | 15.8 |
| 2 | 0.31 | 15.4 | 37 | 3.28 | 17.7 | ||
| 3 | 0.73 | 14.6 | 74 | 7.53 | 20.3 | ||
| 6 | 1.26 | 12.6 | 148 | 12.93 | 17.5 | ||
| AFB2 | 1 | 0.20 | 19.8 | T-2 | 15 | 2.38 | 31.7 |
| 2 | 0.31 | 15.3 | 37 | 2.40 | 13.0 | ||
| 3 | 0.69 | 13.8 | 74 | 2.92 | 7.9 | ||
| 6 | 1.32 | 13.2 | 148 | 6.02 | 8.1 | ||
| AFG1 | 1 | 0.20 | 20.3 | HT-2 | 15 | 2.86 | 19.1 |
| 2 | 0.31 | 15.5 | 37 | 7.23 | 39.1 | ||
| 3 | 0.72 | 14.4 | 74 | 9.85 | 26.6 | ||
| 6 | 1.39 | 13.9 | 148 | 18.92 | 25.6 | ||
| AFG2 | 1 | 0.20 | 19.6 | NIV | 15 | 1.10 | 14.7 |
| 2 | 0.32 | 15.8 | 37 | 1.76 | 9.5 | ||
| 3 | 0.72 | 14.3 | 74 | 4.33 | 11.7 | ||
| 6 | 1.35 | 13.5 | 148 | 11.86 | 16.0 | ||
| OTA | 1 | 0.41 | 41.3 | DON | 15 | 0.69 | 9.2 |
| 2 | 0.83 | 41.6 | 37 | 1.89 | 10.2 | ||
| 3 | 1.42 | 28.4 | 74 | 3.88 | 10.5 | ||
| 6 | 3.11 | 31.1 | 148 | 10.49 | 14.2 | ||
| ZEN | 15 | 2.02 | 13.4 | 3ADON | 15 | 0.85 | 11.4 |
| 37 | 7.21 | 19.5 | 37 | 2.18 | 11.8 | ||
| 74 | 16.66 | 22.5 | 74 | 4.30 | 11.6 | ||
| 148 | 29.22 | 19.7 | 148 | 10.16 | 13.7 | ||
| ZAN | 15 | 1.95 | 13.0 | D3G | 15 | 0.78 | 10.3 |
| 37 | 8.56 | 23.1 | 37 | 1.50 | 8.1 | ||
| 74 | 22.02 | 29.8 | 74 | 3.09 | 8.3 | ||
| 148 | 47.40 | 32.0 | 148 | 11.45 | 15.5 | ||
| α-ZEL | 15 | 2.01 | 13.4 | FB1 | 15 | 1.00 | 6.7 |
| 37 | 5.84 | 15.8 | 37 | 1.22 | 6.6 | ||
| 74 | 14.41 | 19.5 | 74 | 2.40 | 6.5 | ||
| 148 | 33.21 | 22.4 | 148 | 10.74 | 14.5 | ||
| α-ZAL | 15 | 2.66 | 17.8 | FB2 | 15 | 0.50 | 6.7 |
| 37 | 7.80 | 21.1 | 37 | 2.86 | 15.4 | ||
| 74 | 14.86 | 20.1 | 74 | 4.80 | 13.0 | ||
| 148 | 25.70 | 17.4 | 148 | 17.58 | 23.8 | ||
| β-ZEL | 15 | 2.25 | 15.0 | FB3 | 15 | 0.53 | 7.0 |
| 37 | 6.57 | 17.7 | 37 | 2.77 | 15.0 | ||
| 74 | 17.36 | 23.5 | 74 | 3.28 | 8.9 | ||
| 148 | 38.32 | 25.9 | 148 | 16.22 | 21.9 |
Application to commercial and homemade doenjang samples.
| Mycotoxin | Commercial | Homemade | ||||||
|---|---|---|---|---|---|---|---|---|
| Incidence a | Mean (Positive Mean) | Median | Range | Incidence a | Mean (Positive Mean) | Median | Range | |
| AFB1 * | 5/30 | 0.07 (0.40) | 0.33 | 0.11−0.96 | 11/30 | 0.54 (1.48) | 0.65 | 0.19−4.45 |
| AFB2 | 3/30 | 0.08 (0.77) | 0.77 | 0.70−0.84 | 5/30 | 0.14 (0.82) | 0.87 | 0.62−0.98 |
| AFG1 * | 0/30 | - b | - | - | 5/30 | 0.10 (0.60) | 0.57 | 0.49−0.77 |
| AFG2 | 0/30 | - | - | - | 2/30 | 0.03 (0.47) | 0.47 | 0.21−0.73 |
| OTA | 5/30 | 0.80 (4.80) | 0.19 | 0.16−23.27 | 18/30 | 3.05 (5.08) | 3.78 | 0.20−19.68 |
| ZEN ** | 4/30 | 2.79 (20.90) | 17.47 | 5.16−43.48 | 17/30 | 17.82 (31.45) | 19.40 | 5.86−85.50 |
| ZAN * | 0/30 | - | - | - | 5/30 | 0.94 (5.67) | 6.18 | 3.28−7.11 |
| α-ZEL | 0/30 | - | - | - | 1/30 | 0.28 (8.29) | 8.29 | 8.29 |
| α-ZAL | 2/30 | 0.34 (5.17) | 5.17 | 5.13−5.21 | 6/30 | 1.04 (5.21) | 5.01 | 4.05−7.18 |
| β-ZEL * | 0/30 | - | - | - | 5/30 | 1.56 (9.39) | 9.91 | 7.38−11.56 |
| β-ZAL | 5/30 | 0.93 (5.56) | 5.64 | 4.67−6.19 | 3/30 | 1.66 (16.56) | 15.59 | 8.40−25.70 |
| T-2 | 0/30 | - | - | - | 0/30 | - | - | - |
| HT-2 | 1/30 | 0.88 (26.52) | 26.52 | 26.52 | 1/30 | 0.06 (1.69) | 1.69 | 1.69 |
| NIV | 1/30 | 0.26 (7.67) | 7.67 | 7.67 | 6/30 | 0.89 (4.43) | 4.31 | 3.27−6.03 |
| DON | 4/30 | 1.72 (12.88) | 14.25 | 4.78−18.25 | 1/30 | 0.51 (15.35) | 15.35 | 15.35 |
| 3ADON | 0/30 | - | - | - | 0/30 | - | - | - |
| D3G | 0/30 | - | - | - | 1/30 | 0.09 (2.72) | 2.72 | 2.72 |
| FB1 ** | 8/30 | 1.50 (5.61) | 6.64 | 2.21−8.13 | 16/30 | 5.04 (9.44) | 9.39 | 5.52−17.26 |
| FB2 * | 8/30 | 1.57 (5.90) | 6.20 | 1.85−9.11 | 16/30 | 7.00 (13.33) | 6.03 | 3.86−56.19 |
| FB3 | 9/30 | 1.68 (5.60) | 6.10 | 2.48−9.22 | 12/30 | 2.00 (5.00) | 4.96 | 2.37−9.36 |
a: number of positive samples/total number of samples; b: not detected (
Figure 3Co-occurrence and prevalence of mycotoxins in commercial (A,B) and homemade (C,D) doenjang.